Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Amgen's Phase III Findings Show Palifermin Effective In Mucositis

Dec. 10, 2003

By Aaron Lorenzo

Amgen's Phase III Findings Show Palifermin Effective In Mucositis

Dec. 10, 2003

By Aaron Lorenzo

Cancer Diagnostics Company Immunicon Joins IPO Queue

Dec. 10, 2003

By Aaron Lorenzo

Various Phase III Studies Bolster Use Of Rituxan For Treating NHL

Dec. 9, 2003

By Aaron Lorenzo

Various Phase III Studies Bolster Use Of Rituxan For Treating NHL

Dec. 9, 2003

By Aaron Lorenzo

AVI Adds $15M To Balance Sheet Through Direct Equity Placement

Dec. 5, 2003

By Aaron Lorenzo

AVI Adds $15M To Balance Sheet Through Direct Equity Placement

Dec. 5, 2003

By Aaron Lorenzo

Introgen Raises $20 Million To Further Fund Its Cancer Studies

Dec. 2, 2003

By Aaron Lorenzo

Introgen Raises $20 Million To Further Fund Its Cancer Studies

Dec. 2, 2003

By Aaron Lorenzo

Praecis Gets First Approval: Plenaxis In Prostate Cancer

Dec. 1, 2003

By Aaron Lorenzo

Prostate cancer patients gained a new treatment option on Nov. 25 as the FDA approved Plenaxis, a drug fully developed by Praecis Pharmaceuticals Inc. (BioWorld Today)